Inventor · disambiguated record
Garen Manvelian
Also filed as: MANVELIAN GAREN
3 granted patents·1 pending application·11 citations·filing 2016–2024
63Inventor score
Files withREGENERON PHARMA4
Top patents by PatentIndex Score
4 records- 0191US11904017B2Methods for reducing or eliminating the need for lipoprotein apheresis in patients with hyperlipidemia by administering alirocumabREGENERON PHARMA·Filed 2020·Granted Feb 20, 2024·3 cites·20 claims
- 0290US10772956B2Methods for reducing or eliminating the need for lipoprotein apheresis in patients with hyperlipidemia by administering alirocumabREGENERON PHARMA·Filed 2016·Granted Sep 15, 2020·8 cites·17 claims
- 0376US2024261400A1Methods for reducing or eliminating the need for lipoprotein apheresis in patients with hyperlipidemia by administering alirocumabREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 0463US12378557B2Treatment of sepsis with PCSK9 and LDLR modulatorsREGENERON PHARMA·Filed 2021·Granted Aug 5, 2025·0 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Garen Manvelian files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →